| Name: | Apixaban Isopropyl Ester Impurity |
| Catalogue No. | VL3170018 |
| CAS No. | N/A |
| Molecular Formula | C28H30N4O5 |
| Molecular Weight | 502.56 |
| Status | In-stock |
| IUPAC Name | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid isopropyl ester |
| Description | Apixaban Isopropyl Ester Impurity (CAS No: N/A) or 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid isopropyl ester, is a a pyrazole derivative, it acts as Inhibition of factor Xa leads to decreased conversion of factor II to IIa, resulting in decreased thrombin generation and used in treatment and prevent strokes or blood clots. |
| References | Budovich, Aliaksandr, et al. “Role of Apixaban (Eliquis) in the Treatment and Prevention of Thromboembolic Disease.” Pharmacy and Therapeutics, vol. 38, no. 4, 1 Apr. 2013, pp. 206–231, www.ncbi.nlm.nih.gov/pmc/articles/PMC3684191/#b5-ptj3804206. |
